Target intelligence / Profile preview

Pathogenic bacteria in the gut and urogenital tract

Molecular classification
Other
01

Overview

Pathogenic bacteria in the gut and urogenital tract represent a diverse group of microorganisms capable of causing infectious diseases in the human host. In the gastrointestinal tract, common pathogens include species such as Escherichia coli, Salmonella, and Clostridioides difficile, which can lead to diarrhea, inflammation, and systemic illness (NIH, 2023). In the urogenital tract, pathogens like Neisseria gonorrhoeae, Chlamydia trachomatis, and uropathogenic E. coli are frequent causes of urinary tract infections and sexually transmitted diseases (CDC, 2022). These organisms are the primary targets of antimicrobial therapy, which aims to inhibit their growth or kill them by interfering with essential bacterial processes like cell wall synthesis or DNA replication. However, the use of broad-spectrum antibiotics against these pathogens often leads to the collateral damage of beneficial commensal bacteria and the emergence of multi-drug resistant strains (PubMed, 2021).

Other names
Enteric pathogensUrogenital pathogensGastrointestinal pathogensBacterial pathogens
02

Mechanism of action

Antibiotics target various bacterial processes including cell wall synthesis, protein synthesis, DNA replication, and folate metabolism.

03

Biological functions

Other
04

Disease associations

InfectionInflammation
05

Safety considerations

Antibiotic resistanceDisruption of commensal microbiotaClostridioides difficile infectionAllergic reactionsToxicity
06

Interacting drugs

Ciprofloxacin

5 more in the full profile.

07

Biomarkers

C-reactive proteinProcalcitoninBacterial culture16S rRNA sequencingLeukocyte esterase

Beyond the preview

Go deeper on Pathogenic bacteria in the gut and urogenital tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria in the gut and urogenital tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call